Drug Approval | September 15, 2023
Strides receives tentative USFDA approval for Dolutegravir tablets
The products will be manufactured at the company's facility in Bengaluru
The products will be manufactured at the company's facility in Bengaluru
The product is expected to start contributing meaningfully to the revenue from FY25
The hospital hosted a two-day event with top internal and external faculty and medical experts
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
Subscribe To Our Newsletter & Stay Updated
